IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$257M
AUM Growth
-$6.27M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
74
New
Increased
Reduced
Closed

Top Buys

1 +$4.85M
2 +$4.33M
3 +$4.09M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$4.04M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$3.88M

Top Sells

1 +$7.11M
2 +$5.43M
3 +$5.4M
4
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
+$5.01M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.63M

Sector Composition

1 Healthcare 91.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$26.3M 10.24%
180,522
+3,000
2
$22.4M 8.71%
71,508
+10,400
3
$18.3M 7.11%
40,830
-7,300
4
$13.5M 5.25%
88,722
-46,800
5
$12.9M 5.03%
92,141
-4,500
6
$10.4M 4.04%
88,975
+11,500
7
$9.95M 3.87%
122,784
+1,000
8
$9.07M 3.53%
240,773
+103,000
9
$8.25M 3.21%
390,000
+204,766
10
$6.73M 2.62%
36,104
-14,000
11
$6.36M 2.48%
68,384
-49,782
12
$6.3M 2.45%
341,468
13
$6.16M 2.4%
254,334
+47,334
14
$5.75M 2.24%
153,633
-24,010
15
$5.49M 2.14%
121,000
+60,000
16
$5.07M 1.97%
202,000
+144,000
17
$4.91M 1.91%
282,633
+78,000
18
$4.85M 1.89%
+41,300
19
$4.61M 1.8%
56,000
+21,000
20
$4.52M 1.76%
35,000
+1,500
21
$4.09M 1.59%
+273,000
22
$4.04M 1.57%
+66,000
23
$3.95M 1.54%
46,487
+32,060
24
$3.54M 1.38%
86,500
+45,500
25
$3.13M 1.22%
57,500
-7,500